Our Services
Technology Transfer
Kilitch Drugs offers end-to-end pharmaceutical technology transfer services designed to help partner companies and international clients set up or scale their manufacturing operations with confidence.
Our process covers engineering design, process planning, concept design, and basic & detail design, ensuring every facility is built on a strong technical foundation. We manage process engineering and procurement in-house, giving clients a single point of accountability from blueprint to commissioning.
Our turnkey solutions include supply & installation, validation, and commissioning support, so partner facilities are fully operational and compliant from day one. Whether it’s a greenfield project or an upgrade of existing infrastructure, our technology transfer team ensures smooth knowledge transfer, minimal downtime, and adherence to international quality standards throughout the transition.
Beyond the physical setup, our team also supports documentation transfer, staff training, and process validation, so partner facilities aren’t just built correctly but run correctly from the first production batch. We work closely with clients across India, Africa, and the Middle East, adapting our technology transfer approach to local regulatory frameworks and market needs. This makes Kilitch Drugs a reliable long-term partner for companies looking to establish or expand WHO-GMP compliant manufacturing capabilities.
Engineering
Design
Process Planning
Concept Design
Basic & Detail Design
Process Engineering
Procurement
Turnkey
Solution
Supply & Installation
Validation & Commissioning
Tech Transfer
GMP Regulatory
Compliance
Gap Assesment
Document Review
SOP Review
Qualification Review
Facility Design Review
Training
Mock Audit
Dossier Compliance
Assistance
CAPA Preparation
Clients





Research & Development
Innovation drives everything we do at Kilitch Drugs, and our formulation development and R&D unit is central to that mission. Our state-of-the-art R&D facility brings together a skilled team focused on the design, development, and testing of new pharmaceutical formulations across tablets, capsules, injectables, and specialty dosage forms.
This dedicated approach allows us to develop stable, effective, and market-ready products while continuously strengthening our product pipeline for future growth. Our formulation development process is tailored to address both current market demands and emerging healthcare needs, keeping Kilitch Drugs at the forefront of pharmaceutical innovation.
From early-stage formulation optimization to stability studies and regulatory documentation, our R&D team ensures every product meets global quality benchmarks. This strong R&D foundation supports our contract manufacturing and technology transfer clients with formulations that are scientifically validated, scalable, and ready for international markets.
Our R&D efforts also focus on cost-effective formulation without compromising efficacy or safety, helping partner brands offer competitively priced products in price-sensitive markets. By combining scientific rigor with practical manufacturing insight, our formulation development team bridges the gap between lab-stage innovation and commercially viable, regulatory-compliant products ready for global distribution.

Contract Manufacturing Services
Kilitch Drugs is a trusted name in pharma contract manufacturing and third-party manufacturing, offering flexible, scalable solutions across a wide range of dosage forms including tablets, capsules, injectables, liquids, and metered dose inhalers.
As a WHO-GMP certified manufacturing partner, we maintain stringent quality control at every stage of production, from raw material sourcing to final packaging, ensuring consistent, high-quality output batch after batch.
Our contract manufacturing model is built around flexibility — we adapt production schedules, batch sizes, and formulations to match each client’s specific market requirements and regulatory needs. We work closely with domestic and international clients, including pharma companies across Africa and the Middle East, to deliver cost-effective, timely, and compliant manufacturing solutions.
With advanced infrastructure and a dedicated quality assurance team, Kilitch Drugs enables partners to bring reliable, affordable medicines to market faster, without compromising on WHO-GMP standards or product integrity.
We also support clients through the entire product journey — from formulation and regulatory documentation to packaging and logistics — reducing the number of vendors a client needs to coordinate with. Our manufacturing lines are built to handle both small-batch and large-scale orders, making us a suitable partner whether you’re launching a new product or scaling an existing one. This flexibility, combined with consistent WHO-GMP compliance, is why pharma companies across multiple countries choose Kilitch Drugs as their contract manufacturing partner of choice.

GMP Regulatory Compliance
Kilitch Drugs provides comprehensive GMP regulatory compliance support to help pharmaceutical manufacturers meet global quality and regulatory standards. Our services include gap assessment, document review, SOP review, and qualification review to identify and close compliance gaps before they become audit risks.
We also offer facility design review, staff training, and mock audits to prepare client sites for real regulatory inspections with confidence. Our team assists with dossier compliance, regulatory documentation, and CAPA (Corrective and Preventive Action) preparation, ensuring facilities remain inspection-ready and aligned with WHO-GMP and international regulatory requirements at all times.
Our regulatory compliance experts stay updated with evolving WHO-GMP and international pharma regulations, helping client facilities avoid costly non-compliance issues and production delays. Whether you’re preparing for a first-time regulatory audit or maintaining ongoing compliance across multiple manufacturing sites, Kilitch Drugs provides the technical guidance needed to stay audit-ready year-round.
